Cargando…
Angiogenin and MMP-2 as potential biomarkers in the differential diagnosis of gestational trophoblastic diseases
BACKGROUND: Gestational trophoblastic diseases (GTDs) are characterized by vascular abnormalities of the trophoblast, but their pathogenesis is unknown. Angiogenin (ANG) and matrix metalloproteinase (MMP)-2, which are molecules implicated in the angiogenic process, may play some role in this process...
Autores principales: | Weng, Dan, Han, Tao, Dong, Jin, Zhang, Ming, Mi, Yang, He, Yiping, Li, Xiaojuan, Zhu, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812619/ https://www.ncbi.nlm.nih.gov/pubmed/35119039 http://dx.doi.org/10.1097/MD.0000000000028768 |
Ejemplares similares
-
Gestational trophoblastic neoplasia mimicking ruptured ectopic pregnancy: A case report
por: Jiang, Su Zhen, et al.
Publicado: (2023) -
Early pregnancy following multidrug regimen chemotherapy in a gestational trophoblastic neoplasia patient: A case report
por: Niu, Gang, et al.
Publicado: (2017) -
Diagnosis of gestational diabetes: Are five rounds of blood sampling necessary?
por: Cha, Hyun-Hwa, et al.
Publicado: (2022) -
Four differentially expressed exosomal miRNAs as prognostic biomarkers and therapy targets in endometrial cancer: Bioinformatic analysis
por: Yao, Yingsha, et al.
Publicado: (2023) -
Revealing the action mechanisms of dexamethasone on the birth weight of infant using RNA-sequencing data of trophoblast cells
por: Shang, Hongkai, et al.
Publicado: (2018)